While NRF2-inducing properties of DMF or CDDO-Me are frequently emphasized, it is important to recognize that these compounds have multiple, not yet fully understood, modes of action, which may account for their beneficial effects in multifactorial diseases such as PAH. The gene discussed is NFE2L2; the disease is pulmonary arterial hypertension.